Just as washing hands with soap destroys viruses and bacteria on our skin, ErasaVir simulates the same action to destroy pathogens in our nose and throat using plant-based, food-grade fatty acids.

The active ingredient in ErasaVir works by destroying the lipid membrane of the enveloped pathogen on contact, thus destroying it.

Since ErasaVir’s active ingredients are derived from natural substances found in plants, they are not harsh like soaps and perfectly safe to ingest. ErasaVir works on all variants, mutations and alterations of these pathogens.

Nasal and Mouth Spray


ErasaVir is a daily hygiene platform that seeks to make life uninterrupted! ErasaVir nasal and mouth sprays are simple and convenient to use. You can use them daily, at your own convenience. It's best to use it more often if you have been in a crowded place like work, travel, gatherings, etc.

Similar to other daily hygiene habits like brushing teeth, washing hands or using mouthwash, ErasaVir acts as a health companion which rids your upper respiratory tract of pathogens which one might pick up while going about their lives. By inactivating these pathogens early, ErasaVir promises a safer and more secure way to go about our everyday routines.

kills multiple pathogens - like viruses and bacteria.
No adverse side-effects when used as directed
Cleans the Upper Respiratory Tract, ridding it of pathogens regularly
Convenient to carry and use
Infected users may shed fewer pathogens and protect those around them

Nasal Spray

  • Blow your nose slightly before using to clear out any mucous (if required)

  • Pump the spray once or twice to ensure that a mist is being released.

  • Press down one nostril and spray just outside the tip of the other (do not put the nozzle into your nose) pointing away from the centre of the nose(towards the outer wall) and breathe through your mouth while doing so.

  • Repeat in the other nostril.

  • Breathe normally through the mouth (DO NOT sniff/inhale from nose) Massage the nose lightly to spread the product well inside of your nose. Continue to breathe through your mouth while doing so.

  • After a few minutes you may blow your nose to clear any residual congestion.

Mouth Spray

  • Aim the spray towards the back of the throat.

  • Spray twice into your mouth.

  • Spread it around with your tongue to coat the entire surface area inside of the mouth.

Remember

  • Do not twist open the cap of the bottle. Avoid air exposure.

  • Shake both bottles well before using.

  • Consume the contents of the bottle within 60 days of first use.

  • Do not use if you are allergic to any of the ingredients.

  • Use ErasaVir regularly and share this with your family and friends so that we may protect as many people as possible!

FAQ

1What is in the box?

The combo pack contains:

1. Two bottles – a nasal spray and a mouth spray. Together they provide complete Upper Respiratory Protection (URT) protection. There are two ways respiratory pathogens enter our system; through the nose and the mouth. The nasal spray provides protection for the nasal route and the mouth spray for the oral route.

2. A welcome card with a QR code, which you can scan to visit our website.

3. A set of instructions.

2What evidence do you have that ErasaVir is effective?
Four decades of scientific literature forms the basis for the scientific rationale for ErasaVir. It has been extensively studied by ErasaVir’s scientific team, who have decades of experience in this area. That knowledge was moulded into a usable product which could upgrade our protection against enveloped pathogens. During almost 2 years of R&D work on ErasaVir, we conducted a number of studies at a United Nations affiliated BSL-3 lab on live SARS-CoV-2 viruses in-Vito and witnessed a 99%-100% kill rate of the virus with our initial active ingredient thereby validating our thesis. With the final product we observed 100% kill rate.
3Will ErasaVir protect me against the flu?
There is a strong scientific rationale, justification, as well as scientific literature that lead us to believe that ErasaVir could be effective against flu viruses. We are in the process of conducting detailed studies with live flu viruses.
4Is ErasaVir safe to use?
Yes, ErasaVir is safe to use as a daily companion. All the ingredients in ErasaVir have been proven to be safe and categorized as ‘Generally Recognized as Safe’ or ‘GRAS’ by the US FDA. ErasaVir has no adverse side-effects when used as recommended, is suitable for all age groups and is safe for everyone to use daily.
5Will I feel any discomfort when I use ErasaVir? Is it normal to feel a tinge post nasal spray?
The mouth spray is just like a breath freshener. it does not have any potential for irritation. Since the nasal passage is very sensitive, some users may experience some discomfort for a few minutes. However, if used as directed this should not persist. We are continuously collecting feedback to keep improving our users’ experience.
6Should I consult a doctor before using ErasaVir sprays?
Under normal circumstances you don't need to consult a doctor to use ErasaVir. However, if you have any conditions that you think you may need medical advice or if you have any allergic reaction then you should consult a doctor. No user of ErasaVir has reported any allergic reaction to ErasaVir.

Apart from pharmacies near you, ErasaVir is also available at

My account

Login

Lost your password?

Create an account?

Darpan Roy Chowdhury


Darpan Roy Chowdhury

Darpan is committed to exploring innovative areas in healthcare, and finding solutions which can make a difference. He is driven by a desire to create value in the Indian healthcare landscape. He co-founded ErasaVir amidst the pandemic, as he wanted to help the world return to an uninterrupted life. He is on a mission to serve as many people around the globe as possible, with a safe and easy protective solution. He is our go-to person for clearing hurdles and steering through icebergs to achieve the lofty goals imagined by the ErasaVir team.
Darpan also leads business development at Strassenburg Pharmaceuticals. His experiences have ranged from the pharmaceutical manufacturing and marketing sectors, to startups working on new technologies and services – including telemedicine, patient outcomes in healthcare and after-school education.According to him, solutions of any kind (especially in healthcare) must be empathetic to the realities of those they serve. ErasaVir to him represents a step in the right direction-a way to preserve our way of life and reduce the suffering of people worldwide.

This will close in 0 seconds

Dr. Dino Rotondo


Dr. Dino Rotondo

Dr. Rotondo serves as Senior Lecturer in Immunology, Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS),University of Strathclyde, Glasgow UK. During his scientific career he has carried out extensive research on polyunsaturated fatty acids (PUFAs) – particularly in the domain of molecular and cellular mechanisms related to immune function. He has published key research papers on PUFAs and eicosanoid metabolites’ effects on cell function. Dr. Rotondo’s early research work on dexamethasone (1987), demonstrated its systemic anti-inflammatory actions in response to double-stranded RNA mimicking viral activation. This has now become centre-stage in the use of dexamethasone (abreakthrough drug) in thetreatment of Covid-19 hyperinflammation.
Dr. Rotondo serves as CSO at ErasaVir. He is responsible for the scientific rationale which forms the backbone of our platform, and leads our research efforts. He firmly believes that those who have the requisite knowledge to make a difference also have a great responsibility towards humanity – his commitment to ErasaVir is inspired by this belief.

This will close in 0 seconds

Dr. Kumaril Bhargava


Dr. Kumaril Bhargava

Dr. Kumar Bhargava is currently serving as a Chief Executive Officer at Serentrix Therapeutics, a specialty company with focus on ocular pain. Prior to Serentrix; Dr. Bhargava led the Strategic Innovation in External Research & Development Innovation group at Pfizer from 2009 – 2011. He has more than twenty years of experience in drug development and business expansion gained at Abbott Labs, American Pharmaceutical Partners, Procter & Gamble and Johnson and Johnson.Dr. Bhargava received the Chairman’s award given to selected employees for their distinguished performance at Abbott labs.
Dr. Bhargava leads activities related to product development for us. He is driven by the belief that innovations in drug development can radically improve health outcomes across the world.

This will close in 0 seconds

Dr. Vijay Tammara


Dr. Vijay Tammara

Dr. Tammara’s regulatory expertise spans both oral and injectable dosage forms of small molecules, peptides, proteins, monoclonal antibodies and vaccines. He also serves as Sefacor Inc’s Head of Regulatory Affairs – guiding them through the complex regulatory process pertaining to oncology drugs. Dr. Tammara has over 20 years of leadership experience in the field of global regulatory affairs, strategic drug development, and clinical strategy. He has made significant contributions to the approval of several products during his positions of leadership at biotech and large pharmaceutical companies, which includes serving as VP Regulatory Affairs at Frontage Labs and Nuron Biotech Inc., Director Regulatory Affairs at Merck & Co., Inc., Senior Associate Director at Wyeth Pharmaceuticals, and Assistant Director at Sanofi-Synthelabo in Worldwide Regulatory Affairs.
Prior to his industrial experience, he held positions of increasing responsibility in the Office of Clinical Pharmacology and Biopharmaceutics at the US FDA and received several FDA awards for excellence. Dr. Tammara advises us on all regulatory affairs and is committed to ensuring that people all around the world can benefit from ErasaVir’s unique properties.

This will close in 0 seconds

Soumitra Sen


Soumitra Sen

We call Soumitra ‘The Thinker’, as he has shaped his life thinking about innovative brands. He has spent more than 30 years in the advertising industry launching & building consumer brands like Becosules, Gelusil, Nasivion, Nise Gel, Calcium Sandoz, One Touch, Seven Seas etc. FMCG brands that he particularly takes pride in being associated with are Cinthol, Good Knight and Amul.
He has now dedicated himself to ensuring that the world gets back the power and the urge to lead an ‘uninterrupted life’ with the protective acumen of ErasaVir. Soumitra loves his books and is passionate about watching sports sans the ones that promote violence. He pursues the life story of his only daughter who is settled in Sydney by being in touch daily with her via Facetime, WhatsApp Video or Duo.

This will close in 0 seconds

Urvashi Guha


Urvashi Guha

Urvashi has been the quintessential creator all her life. She is forever in the quest of launching brands with innovative stories that touch the heart, mind and soul of the consumer. She has demonstrated this acumen in the past 25 years with brands like Becosules, Gelusil, Nasivion, Seven Seas, Calcium Sandoz, Botox, Juvederm, Philips, Becton Dickinson and others.
Her next milestone is to provide ErasaVir with the equity of an uninterrupted life that is trusted by consumers worldwide. In her spare time one can find her tending to the beautiful plants in her garden, dabbling with art, reading books and being a friend to her two talented daughters who are young women in their own right.

This will close in 0 seconds

Disha Roy Chowdhury


Disha Roy Chowdhury

Disha is a legal professional with experience in IP and civil Law. However, today she focuses on working with consumer products which seek to make a difference. Previously she served in the trademarks department at DP Ahuja, a reputed Intellectual property firm in Kolkata. Following this she was on the legal team at IJM (International Justice Mission) – an NGO that specialises in combatting issues of sex trafficking and child labour. Having a keen interest in people, she always sought roles where she could contribute to society in a meaningful way. During the second wave of the pandemic in India,Disha founded EasyMeds to help patients gain access to Covid-19 medications.
Her true passion, she says, lies in creating products and services that give people the opportunity to choose better. In a world of countless options, she aims to help brands with a difference communicate themselves to the consumer. At ErasaVir she is determined to create meaningful conversations with the global community, in order to inform and educate them in these trying times.

This will close in 0 seconds

Reva Mann


Reva Mann

Reva has almost a decade of experience in corporate legal affairs, and business management. After graduating from law school, Reva spent time at the Centre for Law and Policy Research followed by the United Nations Mechanism for International Criminal Tribunals (UN-MICT), before moving on to Shardul Amarchand Mangaldas as an associate. In addition, she serves as Managing Partner at J.S. Automobiles – a leading automobile distributor in northern India.
Reva brings with her a deep sensibility with respect to ‘Intellectual Property’ and ‘International Business Law’
considerations. Convinced that ErasaVir can make life better for a large number of consumers worldwide, she joined us to address all legal and operational concerns. Very soon, she will be traveling to the US in order to complete her LLM at Columbia University, New York.

This will close in 0 seconds

Deepnath Roy Chowdhury


Deepnath Roy Chowdhury

Deepnath has over 35 years of leadership experience in the Indian pharmaceutical industry. Having founded Strassenburg Pharmaceuticals in 1985, he has since gone on to build the organisation into a respected name in the country’s ethical pharmaceutical marketing sector. Under his aegis, Strassenburg has won several accolades for innovation, financial performance, employee satisfaction and contributions to society. Deepnath is also the immediate past president of the Indian Drug Manufacturer’s Association, and has a wealth of experience in liaising between corporate and governmental bodies. He strongly believes in India’s capabilities to provide the world with affordable, high-quality medication, and advises us on our manufacturing and marketing activities in the country.

This will close in 0 seconds

Hari Menon


Hari Menon

Hari Menon is the CEO of Bigbasket.com, a company he co-founded in December 2011 with a vision of setting up India’s finest online groceries delivery platform. Bigbasket, India’s largest online supermarket, delivers the entire range of groceries and a wide range of household products in 40 cities in India working closely with 30,000 farmers. It delivers more than 4,00,000 orders per day to 15 million customers, relying on a team of 29,000 people.
Hari and Bigbasket are recipients of prominent awards, namely – Consumer Internet Company of the Year by VC Circle Awards 2016; Ranked 4th by YourStory in the Top 100 Indian startups with gravity defying momentum in 2015; Best Startup of the year in 2014 by Bangalore Management Association; Best Online Grocer at the Coca Cola Golden Spoon Awards 2016; First runner up (Silver) at the Global eCommerce Summit Awards held in Barcelona; Best Retail and eCommerce App of the Year at the AWS Mobility Awards 2017; Rated the Top Brand in the Forrester’s India Customer Experience Index 2016. To his independent credit, Hari has been awarded for entrepreneurship by the Indira Group of Institutions; AUDI-RITZ ICON AWARDS from RITZ lifestyle magazine in the category of Entrepreneurship and “Champion of Tomorrow” by CEO INDIA Magazine. He is a regular speaker at most major retail and e-commerce forums/events in India.
With his vast and deep experience; Hari will be invaluable as he advises and guides Palani LLC and the ErasaVir brand to best serve customers globally. His strategic and operational insights will be indispensable to Palani LLC and ErasaVir.

This will close in 0 seconds

Dr. RBN Prasad


Dr. RBN Prasad

Dr. RBN Prasad was the former Chief Scientist and Head of the Centre for Lipid Research at CSIR-Indian Institute of Chemical Technology, Hyderabad. Dr Prasad is a highly distinguished lipid scientist and made outstanding contributions in areas of lipid chemistry and technology for over 45 years. Dr Prasad’s research contributions were aimed at the modernization of vegetable oils, oleochemicals and allied products industry in India, leading to operational efficiency, cost reduction and environmental sustainability.
His contributions were also significant in the basic research related to polyunsaturated fatty acids, surfactants, biolubricants, enzymatic modifications of lipids etc. Dr Prasad has over 275 original research papers in reputed scientific journals, 22 book chapters and 71 Indian and international patents to his credit. In addition he has overseen the transfer of technologies to several industries. Dr Prasad was the recipient of 20 prestigious National awards like CSIR Technology Prize, Technology Development Board’s Best Indigenous Technology, Vasvik Award, Industrial Green Chemistry Award of Green Chemistry Network Centre of ACS etc. Dr Prasad was the National President of Oil Technologists’ Association of India and Association of Food Scientist & Technologists (India). Dr Prasad is also part of several expert committees of Govt. Funding Agencies and Food Regulatory Agencies.
Dr Prasad is providing guidance to the Erasavir Team for the activities related to product development and manufacturing as a scientific advisor.

This will close in 0 seconds

Dr. Suman Kapur


Dr. Suman Kapur

Dr. Kapur presently serves as Senior Professor, Department of Biological Sciences at the Birla Institute of Technology & Science, Pilani (Hyderabad Campus). Her research interests include ‘Genetic markers for vulnerability to chronic human diseases’, ‘Medical devices for field deployment in low resource settings’, and ‘Prevention of diseases through natural products’ among others. Dr. Kapur has a wealth of experience in the field, having authored over 200 published journal articles spanning across a wide range of subjects. She also serves on the boards and governing bodies of multiple Indian and overseas educational and research institutions.
Having created proprietary formulations and devices serving a variety of objectives, Dr. Kapur has brought her research and practical experience to the ErasaVir team, furthering our formulation, efficacy, and general research objectives.

This will close in 0 seconds

Lalit Ambastha


Lalit Ambastha

Lalit is an IP Attorney with more than 14 years of experience in the field of Intellectual Property. Post gaining learning experience during his association with leading IP Law firms, Lalit founded Patentwire, a Patent and Technology Consulting firm, in 2008. Lalit is empanelled as speaker and faculty with Ministry of MSME, Govt. of India, for IP Awareness Programmes organized by the Ministry. He is also empanelled as IP Consultant with Ministry of Skill Development and Entrepreneurship, Government of India.
Lalit has dealt with patents across all major fields of invention for Indian and Overseas Clients including DMRC, Honda, IITs, Novartis, Viber, DBT, and ICAR. His experience is spread across sectors like General Utility, Chemical, Medical, Immunological, Biochemical, Herbal, Agriculture, Biotechnological, Pharmaceuticals, Mechanicals, IT, and Electronics. At ErasaVir, Lalit leads our IP objectives and advises us on all things legal.

This will close in 0 seconds

Anupam Dokeniya


Anupam Dokeniya

Anupam has accumulated entrepreneurial experience in a variety of sectors, but sees innovation in life sciences as his true passion. For over 15 years, he has been working in oncology with fatty acids-this formed the basis of ErasaVir’s ideation. Convinced that there are healthcare solutions which can give hope to humanity during this difficult time, Anupam begun the process of building a collective of scientists and entrepreneurs to sculpt this idea into reality.
Prior to ErasaVir, the devastation caused by cancer had moved Anupam on a deeper level. This led him to form Sefacor – to make a positive difference in the lives of patients (and their loved ones) suffering from deadly tumors, starting with high grade glioma, including GBM (Glioblastoma Multiforme). Before entering the healthcare domain Anupam spent time at Santander Investments, Strategic Capital Management, and The World Bank, in addition to founding NSA Investments and Indus Partners. Anupam’s audacious dream is to regularly serve a billion people by providing them an additional layer of safety with ErasaVir and its subsequent versions.

This will close in 0 seconds

CB Bhattacharya


Dr. CB Bhattacharya

CB Bhattacharya is the H.J. Zoffer Chair in Sustainability and Ethics at the Katz Graduate School of Business, University of Pittsburgh. He is a world-renowned expert in business strategy innovation aimed at increasing both business and social value. His research and teaching focus specifically on how companies can use underleveraged “intangible assets” such as corporate identity, reputation, corporate social responsibility and sustainability to strengthen stakeholder relationships and drive firm market value.
Prof. Bhattacharya has published over 100 articles and has over 37,000 citations per Google Scholar, placing him among the top 50 cited marketing academics per Google Scholar and the top 1% of marketing academics per a Stanford University study. His latest book entitled Small Actions Big Difference: Leveraging Corporate Sustainability to Drive Business and Societal Value was published by Routledge in 2019. He is co-author of the book Leveraging Corporate Responsibility: The Stakeholder Route to Maximizing Business and Social Value and co-editor of the book Global Challenges in Responsible Business, both published by Cambridge University Press.
Prof. Bhattacharya is part of a select group of faculty members that have been named twice to Business Week’s Outstanding Faculty list. He is on the #thinklist of the University of Bath, a list of influential faculty thinkers on issues of responsible business He has won several best paper awards, teaching awards and research prizes. He was also a finalist for the Aspen Institute’s Faculty Pioneer Award in 2007. In addition, he received the Emory Williams Distinguished Teaching Award in 1995, the highest teaching award at Emory University.
Prof. Bhattacharya has conducted research and consulted for many organizations such as Allianz, AT&T, Bosch, Eli Lilly, E.ON, General Mills, Green Mountain Coffee, High Museum of Art, Hitachi Corporation, Procter & Gamble Company, Prudential Bank, Timberland and Unilever.

This will close in 0 seconds

Rajiv Lochan


Rajiv Lochan


Rajiv grew up in the Himalayas. As an engineer, he worked in the United States for over a decade before moving back to India. He has been the primary coordinator of Framingham State University's January Term study abroad programme in India for the past 11 years, and for Colby College's Jan-Plan term in India for the past 6 years.
Committed to the cause of education and community-building, he has served on the Board of Directors of FreeSchools World Literacy (FSWL) -USA, a 501(c)3 organisation that supports informal schools in rural areas of India and Thailand to empower women and children with free education. He is working for Young Girls India, a 501(c)3 organisation that promotes the education of disadvantaged girls, as vice president.
Drawing on his multidisciplinary background in Economics and Engineering, Rajiv oversees initiatives for finding new markets, creating marketing strategies, and educating health care professionals about Erasavir. Having survived a long battle with covid, he is a firm believer of the science behind Erasavir

This will close in 0 seconds